Innovation in Molecular Diagnostics
Headquartered in Bologna, Italy, Studium Genetics is a spin-off company of Alma Mater Studiorum – University of Bologna that develops early diagnosis and prognosis predictive methods in the molecular oncology field, with particular regard to oral cancer. Studium Genetics is a company focused on precision medicine by a groundbreaking genomic and epigenomic testing, which generate reliable clinical data about the biology of each patient with cancer or neurological disorders. Backed by prestigious physicians and institutions, we aim at shifting the standard of care towards more innovative treatments. We focus our attention on epigenetic biomarkers, which have significantly contributed to improved diagnostic…